Tag #Nasal Spray

Showing 1 to 4 of 4 results

cnn.com

🌐 85% Global Worthiness

Sep 12, 16:20

Azelastine Nasal Spray Shows Promise in Preventing Covid-19 and Other Respiratory Infections

A recent study published in JAMA Internal Medicine found that the nasal spray azelastine significantly reduced the risk of Covid-19 infection in a randomized, placebo-controlled trial, suggesting a potential inexpensive preventive measure.

Azelastine Nasal Spray Shows Promise in Preventing Covid-19 and Other Respiratory Infections

A recent study published in JAMA Internal Medicine found that the nasal spray azelastine significantly reduced the risk of Covid-19 infection in a randomized, placebo-controlled trial, suggesting a potential inexpensive preventive measure.

Progress

16% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How was the study conducted, and what are the broader implications of these findings?

The study involved 450 vaccinated adults randomized into azelastine and placebo groups, monitored for Covid-19 and other respiratory viruses. The results suggest azelastine could be a low-cost preventive measure against respiratory infections, comparable in effectiveness to Covid-19 vaccines. Further research is needed to confirm these findings.

npr.org

🌐 85% Global Worthiness

May 30, 16:13

Nasal Spray Shows Promise in Reducing Alzheimer's Brain Inflammation

Joe Walsh, an Alzheimer's patient, received an experimental nasal spray, foralumab, showing reduced brain inflammation without serious side effects; a larger clinical trial is planned.

Nasal Spray Shows Promise in Reducing Alzheimer's Brain Inflammation

Joe Walsh, an Alzheimer's patient, received an experimental nasal spray, foralumab, showing reduced brain inflammation without serious side effects; a larger clinical trial is planned.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate implications of the successful reduction of brain inflammation in Joe Walsh, the first Alzheimer's patient treated with foralumab?

Joe Walsh, an Alzheimer's patient, received an experimental nasal spray containing the monoclonal antibody foralumab, aimed at reducing brain inflammation. Initial results show a decrease in brain inflammation with no serious side effects, although cognitive improvements are yet to be fully assessed. This marks a novel approach to Alzheimer's treatment, targeting inflammation rather than amyloid plaques.

forbes.com

🌐 85% Global Worthiness

Aug 16, 16:18

FDA Approves First Self-Administered Flu Vaccine: FluMist Home

The FDA approved FluMist Home, a self-administered nasal spray flu vaccine, in September 2024, available in 34 states for adults under 50 and children over 2, aiming to increase flu vaccination rates by improving accessibility.

FDA Approves First Self-Administered Flu Vaccine: FluMist Home

The FDA approved FluMist Home, a self-administered nasal spray flu vaccine, in September 2024, available in 34 states for adults under 50 and children over 2, aiming to increase flu vaccination rates by improving accessibility.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How might FluMist Home address existing barriers to flu vaccination, and what are its potential limitations?

FluMist Home's home delivery aims to increase flu vaccination rates, which have hovered around 50% in recent years, below the herd immunity threshold. Increased accessibility may overcome convenience barriers to vaccination, potentially improving public health. The vaccine uses a live, weakened virus, limiting eligibility to certain age groups.

jpost.com

🌐 90% Global Worthiness

Dec 8, 07:05

Novel Nasal-Spray COVID-19 Vaccine Offers Room-Temperature Stability and Global Accessibility

Tel Aviv University scientists created a cheap, room-temperature-stable, nasal-spray COVID-19 vaccine effective against all variants, addressing cold-chain storage and administration challenges, potentially revolutionizing global vaccination.

Novel Nasal-Spray COVID-19 Vaccine Offers Room-Temperature Stability and Global Accessibility

Tel Aviv University scientists created a cheap, room-temperature-stable, nasal-spray COVID-19 vaccine effective against all variants, addressing cold-chain storage and administration challenges, potentially revolutionizing global vaccination.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the new nasal-spray COVID-19 vaccine from Tel Aviv University improve upon existing vaccines, and what is its global significance?

Tel Aviv University researchers developed a room-temperature-stable, nasal-spray COVID-19 vaccine effective against common variants. This inexpensive vaccine eliminates cold-chain storage needs, significantly impacting global vaccination efforts. Unlike previous mRNA vaccines, this peptide-based nanovaccine offers simplified administration and enhanced accessibility.

Showing 1 to 4 of 4 results